These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29473691)

  • 1. Assessing cognitive dysfunction in Parkinson's disease: An online tool to detect visuo-perceptual deficits.
    Weil RS; Schwarzkopf DS; Bahrami B; Fleming SM; Jackson BM; Goch TJC; Saygin AP; Miller LE; Pappa K; Pavisic I; Schade RN; Noyce AJ; Crutch SJ; O'Keeffe AG; Schrag AE; Morris HR
    Mov Disord; 2018 Apr; 33(4):544-553. PubMed ID: 29473691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visuo-cognitive dysfunctions in Parkinson's disease.
    Antal A; Bandini F; Kéri S; Bodis-Wollner I
    Clin Neurosci; 1998; 5(2):147-52. PubMed ID: 10785841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visual dysfunction in Parkinson disease without dementia.
    Uc EY; Rizzo M; Anderson SW; Qian S; Rodnitzky RL; Dawson JD
    Neurology; 2005 Dec; 65(12):1907-13. PubMed ID: 16282276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attentional and perceptual impairments in Parkinson's disease with visual hallucinations.
    Koerts J; Borg MA; Meppelink AM; Leenders KL; van Beilen M; van Laar T
    Parkinsonism Relat Disord; 2010 May; 16(4):270-4. PubMed ID: 20153970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early impairment of cognitive functions in Parkinson's disease.
    Stella F; Gobbi LT; Gobbi S; Oliani MM; Tanaka K; Pieruccini-Faria F
    Arq Neuropsiquiatr; 2007 Jun; 65(2B):406-10. PubMed ID: 17665005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of Boston Qualitative Scoring System for Rey-Osterrieth Complex Figure: evidence from a Parkinson's Diseases sample.
    Scarpina F; Ambiel E; Albani G; Pradotto LG; Mauro A
    Neurol Sci; 2016 Oct; 37(10):1603-11. PubMed ID: 27299429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computerized testing in Parkinson's disease: Performance deficits in relation to standard clinical measures.
    Flannery SL; Jowett T; Garvey A; Cutfield NJ; Machado L
    J Clin Exp Neuropsychol; 2018 Dec; 40(10):1062-1073. PubMed ID: 29978753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of visual misperceptions in patients with Parkinson's disease using single and bistable percepts as testing tools.
    Wadhwa A; Bajaj BK; Pandey S
    Neurol India; 2019; 67(1):123-128. PubMed ID: 30860109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic contributions to distance estimation in Parkinson's disease: a sensory-perceptual deficit?
    Ehgoetz Martens KA; Ellard CG; Almeida QJ
    Neuropsychologia; 2013 Jul; 51(8):1426-34. PubMed ID: 23643554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual dysfunction in Parkinson's disease.
    Weil RS; Schrag AE; Warren JD; Crutch SJ; Lees AJ; Morris HR
    Brain; 2016 Nov; 139(11):2827-2843. PubMed ID: 27412389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which Test Is the Best to Assess Visuo-Cognitive Impairment in Patients with Parkinson's Disease with Mild Cognitive Impairment and Dementia? A Systematic Review and Meta-Analysis.
    Liebermann-Jordanidis H; Roheger M; Boosfeld L; Franklin J; Kalbe E
    J Parkinsons Dis; 2022; 12(6):1749-1782. PubMed ID: 35599499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual perception in Parkinson disease dementia and dementia with Lewy bodies.
    Mosimann UP; Mather G; Wesnes KA; O'Brien JT; Burn DJ; McKeith IG
    Neurology; 2004 Dec; 63(11):2091-6. PubMed ID: 15596755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychological deficits in Parkinson's disease patients with visual hallucinations.
    Ramírez-Ruiz B; Junqué C; Martí MJ; Valldeoriola F; Tolosa E
    Mov Disord; 2006 Sep; 21(9):1483-7. PubMed ID: 16705661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for cognitive deficits in Parkinson's disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument.
    Kalbe E; Calabrese P; Kohn N; Hilker R; Riedel O; Wittchen HU; Dodel R; Otto J; Ebersbach G; Kessler J
    Parkinsonism Relat Disord; 2008; 14(2):93-101. PubMed ID: 17707678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oculo-Visual Dysfunction in Parkinson's Disease.
    Armstrong RA
    J Parkinsons Dis; 2015; 5(4):715-26. PubMed ID: 26599301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired perception of human movements in Parkinson's disease.
    Kloeters S; Hartmann CJ; Pundmann VD; Schnitzler A; Südmeyer M; Lange J
    Behav Brain Res; 2017 Jan; 317():88-94. PubMed ID: 27609647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficits in visuospatial processing contribute to quantitative measures of freezing of gait in Parkinson's disease.
    Nantel J; McDonald JC; Tan S; Bronte-Stewart H
    Neuroscience; 2012 Sep; 221():151-6. PubMed ID: 22796080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity and metric of MiniMental Parkinson and MiniMental State Examination in Parkinson's disease.
    Isella V; Mapelli C; Morielli N; De Gaspari D; Siri C; Pezzoli G; Antonini A; Poletti M; Bonuccelli U; Picchi L; Napolitano A; Vista M; Greco A; Appollonio IM
    Neurol Sci; 2013 Oct; 34(10):1751-8. PubMed ID: 23423464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereopsis in drug naïve Parkinson's disease patients.
    Kim SH; Park JH; Kim YH; Koh SB
    Can J Neurol Sci; 2011 Mar; 38(2):299-302. PubMed ID: 21320837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perceptual abnormalities in Parkinson's disease: top-down or bottom-up processes?
    Flowers KA; Robertson C
    Perception; 1995; 24(10):1201-21. PubMed ID: 8577578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.